drugset / Trial / NCT07421050
Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older
Phase 1
Active not recruiting
80 enrolled
Ab&B Bio-tech Co., Ltd.JS
Yither Biotech Co., Ltd · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The objective of this study was to evaluate the safety of subunit influenza vaccine (adjuvant) in people aged 65 years and older.
Timeline
- Start
- 2025-11-13
- Primary completion
- 2026-12-13
- Completion
- 2026-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Subunit Influenza Vaccine (Adjuvant) | Vaccine | 0.25 ml | Intramuscular |
| Subject | Subunit Influenza Vaccine (Adjuvant) | Vaccine | 0.5 ml | Intramuscular |
| Background | MF59 | Other / unclassified | 0.5 ml | Intramuscular |